As Pennsylvania gave away the overdose reversal drug naloxone at dozens of locations across the state Thursday, its response to the opioid epidemic won praise from the American Medical Association in a first-of-its-kind report.

The state announced Friday that 80 sites distributed a total of 6,105 kits of naloxone Thursday, including 926 in Allegheny County, which trailed top-giver Philadelphia by just 101 kits. Beaver County distributed 42 kits, Butler 66, Westmoreland 127 and Washington 57.

It was a day that would have been hard to imagine as recently as 2016, when Pennsylvania lagged behind in almost every conceivable measure in addressing the issue. Now, just two years removed from having neither an effective prescription drug monitoring program nor any official prescribing guidelines, the state is being lauded as a trailblazer.

Officials from the AMA and the Pennsylvania Medical Society deemed the state a model in its approach to increasing access to treatment for addiction, enhancing access to naloxone and providing comprehensive care to patients with pain.

Advertise with us

"We believe the work being done in Pennsylvania can certainly serve as a national model in many ways," said Dr. Patrice Harris, president-elect of the AMA and chair of its Opioid Task Force, on a conference call with reporters after the report was released.

The report, the first of four analyzing different states' responses to the epidemic, commended Pennsylvania for making "considerable progress" on access to addiction treatment. It lauded the Wolf administration's agreement in November between the state and its seven largest insurers to fully remove prior-authorization requirements for medication-assisted treatment, notably buprenorphine, often referred to by the brand name Suboxone.

"Medicaid and other health insurance companies deserve credit for recognizing there's not a need for prior-authorization policies," said Dr. Danae Powers, president of the Pennsylvania Medical Society. "These policies have delayed or denied care” for many patients.

Dr. Harris called the agreement an important step in ensuring medications are available "without administrative hassle," while being accessible and affordable.

Nate Wardle, press secretary for Pennsylvania’s Department of Health, said the agreement last month was another step in making sure people are provided with opportunities to get treatment.

Advertise with us

"We have to provide them the medication they need, and sometimes the window to get someone into treatment is brief, so we don't want there to be anything that hinders that," he said.

The report praised Pennsylvania for increasing access to naloxone — often referred to by the brand name Narcan — which can reverse an overdose by blocking the effects of opioids on the brain.

"If it weren't for naloxone, thousands more would have died from a drug overdose," Dr. Harris said. "We must do all we can to ensure patients and families who need access to this overdose reversal drug have it."

The officials mentioned Pennsylvania's initiative Thursday to give out free naloxone at nearly 80 locations, including at Sto-Rox Community Resource Center in McKees Rocks, where several people gathered to pick up doses.

At a table, Stacie Brown and Denija DuCasse handed out boxes containing two 4-mg doses of naloxone — as well as directions on how to administer it to people who have overdosed. Police officers and EMS providers administering naloxone have revived more than 20,000 people in Pennsylvania since November 2014, according to the state.

Advertise with us

"Not a lot of people know how accessible it is — that you can walk into a pharmacy and get it," said Ms. Brown, a 46-year-old certified recovery specialist at Onala Recovery House on West Carson Street.

By mid-afternoon, the state had distributed 4,500 naloxone kits, in all, at the 80 locations.

The report cited the state's efforts to combine medical oversight on opioid therapy with access to other pain medications and alternative therapies.

The report also recognized the state insurance department's efforts to review health insurance benefit packages, policies and obligations to enforce mental health and parity laws, which require that psychiatric care is covered just as thoroughly as physical care.

"Pennsylvania already has found violations by health insurance companies, and they are continuing to work to enhance the tools necessary for strong oversight and investigation," Dr. Harris said.

Advertise with us

It also recommended areas of improvement for Pennsylvania: that it identify best practices to ensure patients have access to non-opioid alternatives, and that it improve naloxone use through statewide education efforts.

Mr. Wardle said the administration can't just focus on the success that's been reported, but will continue work on making sure people have access to treatment and to naloxone and to decreasing the number of deaths from fentanyl.

But, Mr. Wardle said, the report exemplifies the administration's "all-hands-on-deck approach" to combating the issue.

"It's easy to set up a work group or task force, but to actually have data and information that shows that what's being done is bringing about real change in helping to address this crisis is very important to the entire Wolf administration," Mr. Wardle said.

Julian Routh: jrouth@post-gazette.com